Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 0,75 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.750 mg corresp. pramipexolum 0.524 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 1,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 1.500 mg corresp. pramipexolum 1.049 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 3,0 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 3.00 mg corresp. pramipexolum 2.097 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 4,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 4.500 mg corresp. pramipexolum 3.146 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 0.125 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0.125 mg corresp. pramipexolum 0.088 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 0.25 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0.25 mg corresp. pramipexolum 0.18 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 0.5 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0.5 mg corresp. pramipexolum 0.35 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 1.0 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 1 mg corresp. pramipexolum 0.7 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 1.5 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 1.5 mg corresp. pramipexolum 1.1 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol mylan 1.5 mg tabletten
mylan pharma gmbh - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 1,5 mg endwerte. pramipexolum 1,1 mg, excipiens pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika